Trials / Completed
CompletedNCT04476771
Cultivating Well-being in Subclinical Paranoia
Cultivating Well-being Beyond Symptomatology in Subclinical Paranoia: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Universidad Complutense de Madrid · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The intervention is called Feliz-Mente, with third generation therapy components that aims to improve wellbeing and self-enhancement. Without intervening directly on the symptoms, it is expected to increase positive experiences, the use of personal strengths and positive relationships, and aims to build a more meaningful self-narrative in persons with subclinical paranoia. Feliz-Mente is a group intervention of 12 sessions in which participants are expected to perform exercises during and between sessions by the use of a mobile application to improve treatment adherence and daily practice. The design for the present study is a randomized controlled trial, which compares the post-intervention measures of the experimental group (group receiving the intervention and the daily use of a mobile application of the program) with the post-intervention measures of the control group (treatment as usual + waiting list).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Feliz-Mente (third generation psychotherapy) | The intervention is delivered in a group format with a total of 12 sessions and a maximum of 10 patients per group. The protocol consists of specific exercises: 1: welcome and identification of emotions, 2: identification and amplification of positive emotions, 3: regulation of negative emotions, 4: gratitude, 5: forgiveness, 6: self-compassion, 7: personal strengths, 8: loving-kindness and positive interpersonal relationships, 9: values, 10: purpose of life, 11: resilience, 12: keeping the change and farewell party. |
Timeline
- Start date
- 2017-10-10
- Primary completion
- 2019-09-25
- Completion
- 2019-09-25
- First posted
- 2020-07-20
- Last updated
- 2020-07-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04476771. Inclusion in this directory is not an endorsement.